Evidence map›Paper›PMID 42137856›Full record

ArticleCase reports in perinatal medicine2026

Primary Hyper-aldosteronism in pregnancy: a case report with review of the literature.

Elie Hobeika, Dalia Malaeb, Dina Chamsy, Abdallah Adra, Nabil El Khoury, Anwar H Nassar

Abstract readCase Reports
In one paragraph

Article in Case reports in perinatal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elie HobeikaDepartment of Obstetrics and Gynecology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Dalia MalaebDepartment of Obstetrics and Gynecology, Kanad Hospital, Al Ain, Abu Dhabi, United Arab Emirates.
Dina ChamsyDepartment of Obstetrics and Gynecology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Abdallah AdraDepartment of Obstetrics and Gynecology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Nabil El KhouryDepartment of Obstetrics and Gynecology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Anwar H NassarDepartment of Obstetrics and Gynecology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.ORCID https://orcid.org/0000-0002-9200-1865

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Primary hyperaldosteronism can present during pregnancy. Due to its rarity and to the physiological changes occurring during pregnancy, diagnosis might be delayed with potential complications imposed on the mother and newborn. Case presentation: We report a 46-years-old middle eastern patient with chronic hypertension, who conceived with assisted reproductive technologies and was diagnosed with PA. She was referred back to cardiology for re-evaluation of her resistant hypertension. Serum electrolytes showed low potassium, high aldosterone, and high renin to aldosterone ratio. Magnetic resonance imaging of the adrenal glands revealed a unilateral nodule in the left adrenal gland. The patient was maintained on three antihypertensives; unfortunately, her pregnancy was complicated by intrauterine growth restriction and preterm delivery for preeclampsia with severe features. Conclusions: Primary hyperaldosteronism is a rare complication of pregnancy that is challenging to diagnose. However, timely and accurate diagnosis are essential to initiate appropriate treatment to ensure optimal fetal and maternal outcomes.

Indexed as

diagnosishypertensionprimary hyper-aldosteronismtreatment

Identifiers

PMID42137856
PMCPMC13168217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.